Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effect of Vestibular Rehabilitation Combined With Dual-Task Training in Patients With Unilateral Vestibular Hypofunction (VRT-DT)

13. november 2026 oppdatert av: Danah Mohammed Alyahya, Majmaah University

The Effect of the Vestibular Rehabilitation Combined With Dual-task Training Among Unilateral Vestibular Hypofunction Patients.

Unilateral vestibular hypofunction (UVH) is a condition in which the balance system in one inner ear does not function properly. People with this condition may experience dizziness, blurred vision during head movements, difficulty maintaining balance, and problems walking, particularly when performing two tasks at the same time.

Vestibular rehabilitation is an exercise-based treatment designed to improve balance, gaze stability, and daily functioning. Dual-task training involves performing a physical activity while simultaneously completing a mental or another physical task, such as walking while counting backward.

The purpose of this study is to investigate whether combining dual-task training with vestibular rehabilitation is more effective than traditional vestibular rehabilitation alone in improving vestibular function, dizziness, balance, and walking ability in adults with unilateral vestibular hypofunction.

This study is a single-blind randomized controlled trial involving 50 adults aged 18 to 65 years with unilateral vestibular hypofunction. Participants will be randomly assigned to one of two groups. The first group will receive traditional vestibular rehabilitation, while the second group will receive vestibular rehabilitation combined with dual-task training. Both groups will complete two treatment sessions per week for four weeks, for a total of eight sessions.

Participants will undergo assessments before and after the four-week intervention to evaluate vestibular function, dizziness-related disability, balance, walking ability, attention, and working memory. The findings may help determine whether adding dual-task training provides additional benefits for people with unilateral vestibular hypofunction.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

50

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Adults aged 18 to 65 years.
  • Patients with a physician-confirmed diagnosis of unilateral vestibular -hypofunction (UVH).
  • Male and female participants.
  • Ability to walk independently and safely for at least 6 meters.
  • Ability to attend at least 80% of the scheduled treatment sessions.

Exclusion Criteria:

  • Patients diagnosed with bilateral vestibular hypofunction.
  • Presence of neurological disorders that affect balance.
  • Presence of musculoskeletal disorders that affect balance.
  • Cognitive impairment affecting task performance, defined as a Montreal -Cognitive Assessment (MoCA) score below 26.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: VR Group

Participants in this group will receive traditional vestibular rehabilitation consisting of gaze stabilization exercises (VOR x1 and VOR x2), habituation exercises, and balance training. Balance exercises will include standing on firm and foam surfaces with eyes open and closed, tandem standing, tandem walking, and walking with head movements. The intervention will be delivered twice weekly for four weeks, totaling eight treatment sessions.

Participants will receive traditional vestibular rehabilitation consisting of gaze stabilization, habituation, and balance exercises. Gaze stabilization includes VOR x1 exercises (1-2 minutes, 2-3 times) and VOR x2 exercises (1 minute, 2-3 times), performed with horizontal and vertical head movements. Habituation exercises involve repeated symptom-provoking movements, such as bending, head rotation, and turning (3-5 repetitions, 2-3 times). Balance training includes standing on firm and foam surfaces with eyes open and closed, tandem standing (30 seconds, 3-5 repetitions), tandem walking (10 steps, 3-5 repetitions), and walking 6 meters with head turns (3-5 repetitions). Participants will attend two sessions per week for four weeks, totaling eight sessions.

Eksperimentell: VR Group With Dual-Task Training

Participants in this group will receive vestibular rehabilitation combined with dual-task training. The intervention will involve performing vestibular and balance exercises simultaneously with cognitive or motor tasks, including backward counting, reciting months in reverse order, naming animals, digit recall, serial subtraction, backward spelling, and walking while carrying a cup of water. The intervention will be delivered twice weekly for four weeks, totaling eight treatment sessions.

Participants will receive vestibular rehabilitation combined with simultaneous cognitive or motor tasks. Exercises include VOR x1 while counting backward from 100; VOR x2 while reciting months in reverse order; standing on foam while naming animals; standing on foam with eyes closed while recalling digit sequences; tandem standing while subtracting seven repeatedly from 100; tandem walking while spelling a five-letter word backward; walking with head turns while carrying a cup of water; and walking 6 meters while counting backward from 50. The intervention combines vestibular and balance activities with secondary tasks to challenge cognitive-motor performance. Participants will attend two sessions per week for four weeks, totaling eight sessions.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Vestibulo-Ocular Reflex (VOR) Gain
Tidsramme: Baseline and immediately after the 4-week intervention

Vestibulo-ocular reflex (VOR) gain will be assessed using the Video Head Impulse Test (vHIT), an objective measure of semicircular canal function. VOR gain will be measured before and after the four-week intervention to evaluate changes in vestibular function and compare the effects of traditional vestibular rehabilitation with vestibular rehabilitation combined with dual-task training.

Baseline and immediately after the 4-week intervention
Change in Vestibular Evoked Myogenic Potential (VEMP) Responses
Tidsramme: Baseline and immediately after the 4-week intervention

Otolith organ function will be assessed using cervical Vestibular Evoked Myogenic Potentials (cVEMP) to evaluate saccular function and ocular Vestibular Evoked Myogenic Potentials (oVEMP) to evaluate utricular function. Assessments will be conducted before and after the four-week intervention to investigate changes in otolith function and compare responses between the two intervention groups.

Baseline and immediately after the 4-week intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

15. november 2026

Primær fullføring (Antatt)

30. desember 2026

Studiet fullført (Antatt)

30. januar 2027

Datoer for studieregistrering

Først innsendt

13. november 2026

Først innsendt som oppfylte QC-kriteriene

13. november 2026

Først lagt ut (Faktiske)

19. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

19. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

13. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • IRB-097-2026

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .